← All patents

US8637503B2

Phenothiazine enantiomers as agents for the prevention of bone loss

University of Texas System

Abstract

Disclosed is the unexpected finding that enantiomers of phenothiazines, preferably the (+) enantiomer of promethazine, are particularly effective in inhibiting the bone resorbing cells, osteoclasts, thus providing new uses and methods for reducing bone loss and, e.g., treating periodontitis and …

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Edward J. Boland
Priority date
May 16, 2003
Filing date
May 17, 2004
Grant date
January 28, 2014
Publication date
January 28, 2014
Language
en
Metadata fetched
August 29, 2026 00:22